GSA Capital Partners’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
GSA Capital Partners's IRMD Position: Q3 2026 in Review
GSA Capital Partners increased its iRadimed (IRMD) stake by 62% in Q3 2026, buying an estimated $395K and bringing the position to 11,458 shares worth $988K. The position accounts for 0.06% of the portfolio, ranked #579.
GSA Capital Partners first reported a position in IRMD in Q3 2015 and has held it in 19 quarters since. The position peaked at $1.41M in Q4 2015. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- GSA Capital Partners held 11,458 shares of iRadimed worth $988K as of Q3 2026.
- GSA Capital Partners bought 4,395 iRadimed shares in Q3 2026, an estimated $395K.
- iRadimed made up 0.06% of GSA Capital Partners's portfolio in Q3 2026, its #579 holding.
- GSA Capital Partners first reported a position in iRadimed in Q3 2015 and has held it in 19 quarters since.
- GSA Capital Partners's iRadimed position peaked at $1.41M in Q4 2015.
- 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.